IPO

Adial Pharmaceuticals' $64 Million Acquisition of Azora: What It Means for Biotech Investors

Adial Pharmaceuticals' acquisition of Azora Therapeutics signals strategic growth in the biotech sector, particularly for ulcerative colitis…

Jun 11, 2026
IPO

SpaceX IPO at $135: Nasdaq Debut, $85.7B Raised and SPCX Stock Since

SpaceX priced its record IPO at $135 a share on June 11, 2026, raising about $85.7 billion, and SPCX began trading on Nasdaq on June 12. The…

Jun 11, 2026
IPO

GSK's $10.6B Nuvalent Play: What Big Pharma's Consolidation Appetite Means for the Market

GlaxoSmithKline's $10.6 billion acquisition of Nuvalent signals continued M&A momentum in pharma, reshaping the competitive landscape.

Jun 9, 2026
IPO

Alphabet's $80 Billion Stock Sale: Analyzing Implications for Investors and the AI Market

Alphabet plans a massive $80 billion stock sale to fund AI developments, raising key investor questions about share prices and market positi…

Jun 3, 2026
IPO

Factorial Energy's SPAC Merger: What Investors Should Know

Factorial Energy's merger with Cartesian Growth Corporation III is set to shake up the EV battery sector. Here's what traders need to know.

May 28, 2026
IPO

ProLogium's Upcoming Nasdaq Listing: What Investors Should Know

ProLogium is set to make waves on Nasdaq through a SPAC merger. Dive into what this means for the battery sector.

May 27, 2026
IPO

New Energy Royalty Company Emerges: SoftVest and Blackbeard's Strategic Move

SoftVest and Blackbeard Holdings announce a significant business combination aimed at enhancing energy sector investments.

May 19, 2026